Monthly Archives: March 2013

“The Technology is Here, It’s Ready”

Refinery

Last week the Milken Institute, a nonpartisan economic think tank, released a Financial Innovations Lab Report: Unleashing the Power of the Bio-Economy. The Milken Institute hosted a Financial Innovations Lab on industrial biotech in April of 2012 to explore ideas to spur the industry, bringing together leading scientists, senior government officials, industry executives, institutional investors and venture capitalists. Tremendous potential for economic and environmental benefits exist with using biobased chemicals instead of petrochemicals. Thanks to Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,

Forbes 30 Under 30: Rising Biotech Stars at the 2013 BIO International Convention

Forbes 30 Under 30

For the second year in a row, Forbes magazine published a list of the most awe-inspiring rising stars in science and healthcare – all under the age of 30. A select group of these rising stars will attend the 2013 BIO International Convention and participate in a Keynote Luncheon Tuesday, April 23, with BIO President and CEO Jim Greenwood. Keynotes and evening events are open to Convention Access and Full Convention Access Registrations! Registration discounts Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Debunking Ag Biotech’s Top 5 Myths

Book

On Reason.com, award-winning science correspondent Ronald Bailey takes on the Institute for Responsible Technology (IRT), an organization opposed to crop biotechnology. IRT published a list of reasons to avoid GMOs. Bailey says, “it’s a mish-mash of misinformation and disinformation. All of the institute’s assertions are unfounded.” In a detailed article chock full of scientific cites, Bailey debunks the following IRT Myths: 1. “GMOs Are Unhealthy” 2. “GMOs Increase Herbicide Use” 3. “Genetic Engineering Creates Dangerous Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

BIO-Europe Spring Opening Remarks

Chart

BIO’s own David Thomas, Director of Industry Research, delivered opening remarks at the BIO-Europe Spring conference in Barcelona yesterday. His slides provide a snapshot of the biotech industry’s performance and highlight emerging trends in venture exits: IPOs and M&A. Takeaways from his talk include breakouts on multiple fronts for the industry: FDA approvals at highs not seen since the 1990s Orphan designation approvals at all-time highs IPOs starting to show signs of life in 2012 Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Convention Veterans Putting the “Super” in Super Sessions

Worldview

Featured in the BIO Buzz Center at last year’s Convention, two of our Super Session participants will once again join us to host a dynamic group of C-level industry thought leaders, sharing their perspectives on the current economic environment and major trends that will impact the future of the global industry. Ernst & Young will present insights from their annual report which looks to measure the industry performance through key metrics such as financial results, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,